These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10213363)

  • 21. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians.
    Tai HL; Krynetski EY; Yates CR; Loennechen T; Fessing MY; Krynetskaia NF; Evans WE
    Am J Hum Genet; 1996 Apr; 58(4):694-702. PubMed ID: 8644731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicity.
    Liu C; Janke LJ; Yang JJ; Evans WE; Schuetz JD; Relling MV
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):287-293. PubMed ID: 28623449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of SNaPshot for analysis of thiopurine methyltransferase gene polymorphism.
    Kapoor G; Maitra A; ; Brahmachari V
    Indian J Med Res; 2009 May; 129(5):500-5. PubMed ID: 19675376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB; Barclay ML
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.
    Wang L; Weinshilboum R
    Oncogene; 2006 Mar; 25(11):1629-38. PubMed ID: 16550163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase.
    Krynetski EY; Schuetz JD; Galpin AJ; Pui CH; Relling MV; Evans WE
    Proc Natl Acad Sci U S A; 1995 Feb; 92(4):949-53. PubMed ID: 7862671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase.
    Weinshilboum R
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 2):601-5. PubMed ID: 11259360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacology and pharmacogenetics of thiopurines.
    Sahasranaman S; Howard D; Roy S
    Eur J Clin Pharmacol; 2008 Aug; 64(8):753-67. PubMed ID: 18506437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.
    Relling MV; Schwab M; Whirl-Carrillo M; Suarez-Kurtz G; Pui CH; Stein CM; Moyer AM; Evans WE; Klein TE; Antillon-Klussmann FG; Caudle KE; Kato M; Yeoh AEJ; Schmiegelow K; Yang JJ
    Clin Pharmacol Ther; 2019 May; 105(5):1095-1105. PubMed ID: 30447069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiopurine S-methyltransferase activity in Japanese subjects: metabolic activity of 6-mercaptopurine 6-methylation in different TPMT genotypes.
    Nishida A; Kubota T; Yamada Y; Higashi K; Kitamura K; Nakahara K; Iga T
    Clin Chim Acta; 2002 Sep; 323(1-2):147-50. PubMed ID: 12135816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TPMT Polymorphism: When Shield Becomes Weakness.
    Katara P; Kuntal H
    Interdiscip Sci; 2016 Jun; 8(2):150-155. PubMed ID: 26297310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of thiopurine methyltransferase--optimization of drug dosage and potential drug interactions.
    Lennard L
    Ther Drug Monit; 1998 Oct; 20(5):527-31. PubMed ID: 9780130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of thiopurine S-methyltransferase gene knockdown in jurkat T-lymphocytes: an in vitro model of TPMT polymorphism.
    Misdaq M; Andag R; Oellerich M; Asif AR; von Ahsen N
    Ther Drug Monit; 2012 Oct; 34(5):584-92. PubMed ID: 22972540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canine red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics.
    Salavaggione OE; Kidd L; Prondzinski JL; Szumlanski CL; Pankratz VS; Wang L; Trepanier L; Weinshilboum RM
    Pharmacogenetics; 2002 Dec; 12(9):713-24. PubMed ID: 12464800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity.
    Tai HL; Krynetski EY; Schuetz EG; Yanishevski Y; Evans WE
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6444-9. PubMed ID: 9177237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The thiopurines: an update.
    Coulthard S; Hogarth L
    Invest New Drugs; 2005 Dec; 23(6):523-32. PubMed ID: 16267626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allelic variants of the thiopurine S-methyltransferase deficiency in patients with ulcerative colitis and in healthy controls.
    Corominas H; Domènech M; González D; Diaz C; Roca M; García-González MA; Peña S; Baiget M
    Am J Gastroenterol; 2000 Sep; 95(9):2313-7. PubMed ID: 11007234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.
    Coulthard SA; Matheson EC; Hall AG; Hogarth LA
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1385-91. PubMed ID: 15571264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of thiopurine S-methyltransferase genotyping.
    Corominas H; Baiget M
    Am J Pharmacogenomics; 2004; 4(1):1-8. PubMed ID: 14987117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.
    Honchel R; Aksoy IA; Szumlanski C; Wood TC; Otterness DM; Wieben ED; Weinshilboum RM
    Mol Pharmacol; 1993 Jun; 43(6):878-87. PubMed ID: 8316220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.